Gallacher L, Murdoch B, Wu D M, Karanu F N, Keeney M, Bhatia M
The John P. Robarts Research Institute, London, Ontario, Canada.
Blood. 2000 May 1;95(9):2813-20.
Recent evidence indicates that human hematopoietic stem cell properties can be found among cells lacking CD34 and lineage commitment markers (CD34(-)Lin(-)). A major barrier in the further characterization of human CD34(-) stem cells is the inability to detect this population using in vitro assays because these cells only demonstrate hematopoietic activity in vivo. Using cell surface markers AC133 and CD7, subfractions were isolated within CD34(-)CD38(-)Lin(-) and CD34(+)CD38(-)Lin(-) cells derived from human cord blood. Although the majority of CD34(-)CD38(-)Lin(-) cells lack AC133 and express CD7, an extremely rare population of AC133(+)CD7(-) cells was identified at a frequency of 0.2%. Surprisingly, these AC133(+)CD7(-) cells were highly enriched for progenitor activity at a frequency equivalent to purified fractions of CD34(+) stem cells, and they were the only subset among the CD34(-)CD38(-)Lin(-) population capable of giving rise to CD34(+) cells in defined liquid cultures. Human cells were detected in the bone marrow of non-obese/severe combined immunodeficiency (NOD/SCID) mice 8 weeks after transplantation of ex vivo-cultured AC133(+)CD7(-) cells isolated from the CD34(-)CD38(-)Lin(-) population, whereas 400-fold greater numbers of the AC133(-)CD7(-) subset had no engraftment ability. These studies provide novel insights into the hierarchical relationship of the human stem cell compartment by identifying a rare population of primitive human CD34(-) cells that are detectable after transplantation in vivo, enriched for in vitro clonogenic capacity, and capable of differentiation into CD34(+) cells. (Blood. 2000;95:2813-2820)
最近有证据表明,人类造血干细胞特性可在缺乏CD34和谱系定向标志物(CD34(-)Lin(-))的细胞中发现。进一步鉴定人类CD34(-)干细胞的一个主要障碍是无法使用体外检测法检测到该细胞群体,因为这些细胞仅在体内表现出造血活性。利用细胞表面标志物AC133和CD7,从人脐带血来源的CD34(-)CD38(-)Lin(-)和CD34(+)CD38(-)Lin(-)细胞中分离出亚群。虽然大多数CD34(-)CD38(-)Lin(-)细胞缺乏AC133并表达CD7,但鉴定出了频率为0.2%的极其罕见的AC133(+)CD7(-)细胞群体。令人惊讶的是,这些AC133(+)CD7(-)细胞高度富集祖细胞活性,其频率与纯化的CD34(+)干细胞部分相当,并且它们是CD34(-)CD38(-)Lin(-)群体中唯一能够在特定液体培养中产生CD34(+)细胞的亚群。在移植从CD34(-)CD38(-)Lin(-)群体中分离的体外培养的AC133(+)CD7(-)细胞8周后,在非肥胖/严重联合免疫缺陷(NOD/SCID)小鼠的骨髓中检测到人类细胞,而AC133(-)CD7(-)亚群的细胞数量多400倍却没有植入能力。这些研究通过鉴定一种罕见的原始人类CD34(-)细胞群体,为人类干细胞区室的层级关系提供了新的见解,这种细胞在体内移植后可检测到,富集体外克隆形成能力,并能够分化为CD34(+)细胞。(《血液》。2000年;95:2813 - 2820)